(¿Â¶óÀÎ) 2022 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ(ICKSH 2022)-4¿ù 1ÀÏ(2ÀÏÂ÷) : 2022-04-01±³À°ÀÏÀÚ : 2022-04-01
±³À°Àå¼Ò : ¿Â¶óÀÎ
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ) 2022 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ(ICKSH 2022)-4¿ù 1ÀÏ(2ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ
´ã´çÀÚ : Çѹ®¼÷
¿¬¶ôó : 02-566-6031
À̸ÞÀÏ :
icksh@icksh.org ±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Áø´Ü°Ë»çÀÇÇаú
Âü¼®¿¹»óÀοø : 500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 7 ½Ã°£ 25ºÐ
¼¼ºÎ¼ö°·á : 150,000¿ø
ºñ°í 100,000¿ø(2¿ù 28ÀÏ ÀÌÀü±îÁö)
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04-01 Room 1 09:00~09:25 Biologic and clinical consequences of the BRAFV600E mutation in langerhans cell histiocytosis Kenneth McClain(Texas Children's Cancer Center USA)
±³À°½Ã°£ 04-01 Room 1 09:25~09:50 Advances in the diagnosis and treatment of hemophagocytic lymphohistiocytosis Kim E. Nichols(St. Jude Children's Research Hospital USA)
±³À°½Ã°£ 04-01 Room 1 09:50~10:10 Current status of diagnosis and treatment of langerhans cell histiocytosis in Korea °í°æ³²(¿ï»êÀÇ´ë)
±³À°½Ã°£ 04-01 Room 1 10:10~10:30 Adult hemophagocytic lymphohistiocytosis in Korea ±è¼®Áø(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 04-01 Room 1 10:30~11:15 Rational development of targeted therapies to cure molecular subtypes of DLBCL(diffuse large B-cell lymphoma) Louis M. Staudt(National Cancer Institute USA)
±³À°½Ã°£ 04-01 Room 2 11:30~12:10 The updated information of ponatinib use in chronic myeloid leukemia Jorge E. Cortes(Georgia Cancer Center USA)
±³À°½Ã°£ 04-01 Room 2 12:10~12:40 Diabetic Foot Ulcer as a Manifestation of T-Cell Lymphoma: A Case Report Jumria Tandi Panggalo(Universitas Lambung Indonesia)
±³À°½Ã°£ 04-01 Room 2 12:40~13:40 Long-term Real-world Experience of Castleman¡¯s Disease Treatment ¹Î±âÁØ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 04-01 Room 2 14:40~15:10 Chemotherapy vs. allogeneic HSCT( Hematopoietic Stem Cell Transplantation) for Phnegative adult ALL(acute lymphocytic leukemia) Josep-Maria Ribera(ICO-Hospital Germans Trias i Pujol Spain)
±³À°½Ã°£ 04-01 Room 2 15:10~15:40 Clonal heterogeneity in ALL(acute lymphocytic leukemia) Sophie Park(CHU de Grenoble Service hematologie clinique France)
±³À°½Ã°£ 04-01 Room 2 15:40~16:10 Challenges in the diagnosis and treatment of overlap MDS(myelodysplastic syndrome)/MPN syndromesmyeloproliferative neoplasm) Antonio Almeida(Hospital da Luz Lisboa Portugal)
±³À°½Ã°£ 04-01 Room 4 16:25~16:55 Lymphoma pathology: basic immunohistochemisty for lymphoma diagnosis Á¶ÁØÈÆ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 04-01 Room 4 16:55~17:25 Staging and response assessment of lymphoma À¯ÄèÇÑ(°¡ÃµÀÇ´ë)
±³À°½Ã°£ 04-01 Room 4 17:25~17:55 Treatment of indolent lymphoma Á¤¼ºÇö(ÀÎÇÏÀÇ´ë)